Pericarditis clinical trials
The registry lists 54 studies for Pericarditis across more than 10 countries. 23 are recruiting or about to start. 32 of them are mainly about Pericarditis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06.
Get an email when these change. Save the Pericarditis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Who runs them
Azienda Sanitaria Locale 3, Torino (4) · Kiniksa Pharmaceuticals International, plc (3) · Assistance Publique - Hôpitaux de Paris (3) · St. Vincent Cardiovascular Research Institute (2) · Kiniksa Pharmaceuticals (UK), Ltd. (2) · Ottawa Heart Institute Research Corporation (2) · R-Pharm International, LLC (2) · Hippocration General Hospital (2)
What is being tested here
Drugs under test in Pericarditis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 8, phase 3 first
- Feb 2027Pericardial Imaging Study · Phase 3 · Ottawa Heart Institute Research Corporation
- Dec 2026Genomics and COVID-19 Vaccine Adverse Events · University of British Columbia
- Dec 2026COVID-19 Vaccine-induced Inflammatory Heart Disease Prevalence Registry · Ottawa Heart Institute Research Corporation
- Mar 2027MYocarditis and/or Pericarditis Following mRNA COVID-19 VACCination National Surveillance Study · Cardiology Research UBC
- Jul 2027RUDRA Registry (Real-World Clinical Registry for Patients With Recurrent Pericarditis) · Eurasian Association of Therapists
- Aug 2027EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases · Assistance Publique - Hôpitaux de Paris
- Oct 2027An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis · Zomagen Biosciences Ltd.
- Nov 2027Heart@Home Safety and Efficacy of Hospital-at-Home Care Versus Standard Hospitalization in Cardiac Patients · Tel-Aviv Sourasky Medical Center
Who these studies take
Of the 16 Pericarditis studies recruiting now, 9 (56%) set no upper age limit and 2 (13%) stop at 75 or younger. 6 (38%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 3 (19%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 6 (38%) | 6 (38%) |
| 18 | 16 (100%) | 16 (100%) |
| 30 | 15 (94%) | 15 (94%) |
| 40 | 15 (94%) | 15 (94%) |
| 50 | 15 (94%) | 15 (94%) |
| 65 | 15 (94%) | 15 (94%) |
| 75 | 15 (94%) | 15 (94%) |
| 85 | 12 (75%) | 12 (75%) |
Across all 54 studies, recruiting or not: 15% stop at 75 or younger and 11% at 65; 35% take children; 0% are for women only and 2% for men only; 19% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
What changed recently
From the registry's own updates since Oct 11, 2026.
Started recruiting1
- Pericardial Imaging StudyNov 3, 2026NCT07245849
Newly registered1
Studies
Recruiting first, then most recently updated. Showing 50 of 54. Browse all 54 → or search them.
- MYocarditis and/or Pericarditis Following mRNA COVID-19 VACCination National Surveillance StudyRecruitingNCT061031231 country
- Pericardial Imaging StudyRecruitingNCT07245849Phase 31 country
- Heart@Home Safety and Efficacy of Hospital-at-Home Care Versus Standard Hospitalization in Cardiac PatientsRecruitingNCT07913152Not applicable1 country
- Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387RecruitingNCT07010159Phase 2/310 countries
- Transition to KPL-387 Monotherapy Dosing & Administration StudyRecruitingNCT07288216Phase 210 countries
- An Open-Label Pilot Study of VTX2735 in Recurrent PericarditisRecruitingNCT06836232Phase 24 countries
- JOint Use of Database to Identify Risk Factors of CARDio-vascular Toxicity Induced by Immune Checkpoint InhibitorsRecruitingNCT042947711 country
- CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)RecruitingNCT06708299Phase 34 countries
- Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular ResearchNot yet recruitingNCT07737470
- EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular DiseasesRecruitingNCT070773041 country
- Genomics and COVID-19 Vaccine Adverse EventsRecruitingNCT052127921 country
- CACP: Study on Camptodactyly - Arthropathy - Coxa Vara - Pericarditis (CACP) SyndromeRecruitingNCT074684613 countries
- COVID-19 Vaccine-induced Inflammatory Heart Disease Prevalence RegistryRecruitingNCT050460021 country
- Multimodal Analysis of Endomyocardial BiopsiesRecruitingNCT073596901 country
- Multicenter Study on Cardiovascular and Metabolic Complications in Patients With Biochemically Silent Pheochromocytomas and ParagangliomasEnrolling by invitationNCT073160751 country
- Cardiac Magnetic Resonance for Diagnosing and Guiding Treatment in Concealed Myocardial RuptureEnrolling by invitationNCT070276831 country
- COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG WearableEnrolling by invitationNCT067635491 country
- Pericardial Fluid Analysis in Recurrent PericarditisEnrolling by invitationNCT062939241 country
- Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR LevelsRecruitingNCT059257902 countries
- Inflammation in Acute Cardiovascular Diseases - the CArdiovascular Inflammation Registry (CAIR)Not yet recruitingNCT06411340
- Therapy Management in Patients Treated With Anakinra Due to Recurrent PericarditisRecruitingNCT06071156Not applicable1 country
- Therapeutic Approach in Colchicine-resistant Recurrent pEricarditis in ChildrenNot yet recruitingNCT05805930Phase 3
- Prognostic Biomarkers in Patients With Acute PericarditisRecruitingNCT027547131 country
- Inflammatory Cardiomyopathy Bern RegistryCompletedNCT047745491 country
- RUDRA Registry (Real-World Clinical Registry for Patients With Recurrent Pericarditis)Active, not recruitingNCT065179661 country
- Effects of Pulmonary Rehabilitation Versus Standard Care in Patients With PericarditisActive, not recruitingNCT07716696Not applicable1 country
- REgiStry Of the NAtural History of recurreNt periCarditis in pEdiatric and Adult PatientsActive, not recruitingNCT046873581 country
- Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19Active, not recruitingNCT05619653Phase 32 countries
- Impact of CardiolRxTM on Recurrent Pericarditis (MAvERIC-Pilot)CompletedNCT05494788Phase 21 country
- A Study on the Clinical Course, Outcomes and Risk Factors of Myocarditis and Pericarditis After Moderna COVID-19 VaccineCompletedNCT061136924 countries
- Post-Ablation Pericarditis Reduction Study (PAPERS)CompletedNCT06731595Phase 21 country
- Study of the Safety and Efficacy of RPH-104 in Preventing Recurrences in Patients With Idiopathic Recurrent PericarditisActive, not recruitingNCT05673902Phase 31 country
- Efficacy and Safety of RPH-104 Treatment in Patients With Recurrent PericarditisSuspendedNCT05107934Phase 2/31 country
- ACAM2000® Myopericarditis RegistryCompletedNCT013950821 country
- Dexamethasone Compared to Non-steroidal Anti-inflammatory Drugs in the Treatment of Acute PericarditisTerminatedNCT04323280Phase 41 country
- Study to Assess the Efficacy and Safety of Rilonacept Treatment in Participants With Recurrent PericarditisCompletedNCT03737110Phase 34 countries
- Adverse Myocardial and Vascular Side Effects of Immune Checkpoint InhibitorsCompletedNCT045868941 country
- Improvement of the Etiological Diagnosis of the PericarditisCompletedNCT02828085Not applicable1 country
- Hydroxychloroquine in Colchicine-Resistant Glucocorticoid-Dependent Idiopathic Recurrent PericarditisStatus unknownNCT05737680Phase 31 country
- Post-Ablation Pericarditis Reduction StudyCompletedNCT04906720Phase 21 country
- Study to Evaluate the Efficacy and Safety of RPH-104 Treatment in Patients With Idiopathic Recurrent PericarditisCompletedNCT04692766Phase 2/31 country
- Pericarditis: Auto-Inflammation in Recurrent DiseaseStatus unknownNCT049961081 country
- A Pilot Study of KPL-914 in Recurrent PericarditisCompletedNCT03980522Phase 21 country
- Treatment of Acute Pericarditis With AnakinraTerminatedNCT03224585Phase 21 country
- A Survey of Hospitalizations in Cardiology Units in Sub-Saharan AfricaStatus unknownNCT0323144913 countries
- Management of Pericarditis in Children.Status unknownNCT032533151 country
- AnakInRa for Treatment of Recurrent Idiopathic Pericarditis (AIRTRIP)CompletedNCT02219828Phase 41 country
- Apolipoprotein CIII Reduction Via ColchicineCompletedNCT02083510Early Phase 11 country
- Study of Colchicine to Treat and Prevent Recurrent Pericarditis After Failure of Conventional Treatment.CompletedNCT00235079Phase 41 country
- Study of Colchicine to Treat Acute Pericarditis and Prevent RecurrencesCompletedNCT00128453Phase 31 country